Sonoma Pharmaceuticals (SNOA) FCF Margin Growth (5y) (2015 - 2026)
Sonoma Pharmaceuticals (SNOA) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,437.00 |
| Mar 31, 2026 | 5,881.00 |
| Dec 31, 2025 | -3,220.00 |
| Sep 30, 2025 | -454.00 |
| Jun 30, 2025 | -1,220.00 |
| Mar 31, 2025 | 9,318.00 |
| Dec 31, 2024 | 3,200.00 |
| Sep 30, 2024 | 2,249.00 |
| Jun 30, 2024 | -4,319.00 |
| Mar 31, 2024 | 6,793.00 |
| Dec 31, 2023 | 1,011.00 |
| Sep 30, 2023 | 2,728.00 |
| Jun 30, 2023 | 6,389.00 |
| Mar 31, 2023 | -365.00 |
| Dec 31, 2022 | 3,202.00 |
| Sep 30, 2022 | 452.00 |
| Jun 30, 2022 | 8,586.00 |
| Mar 31, 2022 | 843.00 |
| Dec 31, 2021 | 84,542.00 |
| Sep 30, 2021 | 2,433.00 |